Acer Therapeutics to pause trial of hot flashes drug
Acer Therapeutics Inc said it will pause the trial of its experimental drug to treat menopausal symptoms that failed to reduce the frequency or severity of hot flashes in post-menopausal women, sending its shares down over 40% before the bell.